Sign in

CIK 0001844417 · <br>Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
861314502
Phone
(510) 318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Option exercise CEO acquired 100,000 shares (option exercise)
  4. 4 Option exercise Chief Financial Officer acquired 100,000 shares (option exercise)
  5. 4 Open-market buy Chief Financial Officer bought 2,100 shares at an average $1.24 ($2,594)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Other disposition 10% owner disposed of 255,000 shares (other)
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 1 of 2 · 33 filings